Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
公司代碼SNOA
公司名稱Sonoma Pharmaceuticals Inc
上市日期Jan 26, 2007
CEOTrombly (Amy)
員工數量168
證券類型Ordinary Share
年結日Jan 26
公司地址5445 Conestoga Court, Suite 150
城市BOULDER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編80301
電話18007599305
網址https://sonomapharma.com/
公司代碼SNOA
上市日期Jan 26, 2007
CEOTrombly (Amy)